Examines the blockbuster returns from US government investment in global health R&D, including the lifesaving tools advanced and the economic and health benefits generated globally and domestically.
Interactive online tool and individualized state fact sheets documenting how US investments in global health R&D are delivering economic and health benefits across American states.
This six-part fact sheet series examines the contributions of US government agencies to advancing global health R&D. The series includes the US Agency for International Development, National Institutes of Health, Centers for Disease Control and Prevention, Biomedical Advanced Research and Development Authority, Department of Defense, and Food and Drug Administration.
Ahead of the 2023 reauthorization of the Biomedical Advanced Research and Development Authority (BARDA), the Pandemic and All Hazards Preparedness Act (PAHPA) 2023 policy memo outlines GHTC’s priorities for the reauthorization of BARDA.
Find out about GHTC’s membership options and the benefits of becoming a member.
Learn MoreWe bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.
